Emily Chan

Company: Amgen

Job title: Executive Medical Director, Oncology Global Development

Seminars:

Learnings from the RAS-Targeted Therapeutics Clinical Trials of Sotorasib 9:00 am

• Showcasing where the approved KRAS inhibitors are today and how they get there • Reviewing learnings from the sotorasib development journey • Exploring what the future of monotherapies and combination regimes holdRead more

day: Day Two

Interrogating Innovative Trial Designs to Improve Patient Stratification & Streamline Clinical Progression 2:30 pm

From adaptive and basket trials, to biomarker-driven approaches, innovative trial design offers promising avenues in precision oncology for RAS-driven cancers. Such enhanced trail designs require careful consideration to encompass tumor heterogeneity, resistance risks and optimal dosing strategies. With many nuances to consider, this workshop will review the recent advancements that have underscored tailored treatment approaches…Read more

day: Workshop F